# The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation

> **NCT04096768** · PHASE3 · UNKNOWN · sponsor: **Lebanese American University Medical Center** · enrollment: 394 (estimated)

## Conditions studied

- ICU Patients
- Sedation

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT04096768
- **Lead sponsor:** Lebanese American University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-16
- **Primary completion:** 2021-09-16
- **Final completion:** 2021-12-30
- **Target enrollment:** 394 (ESTIMATED)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096768, "The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04096768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*